Endpoint definition
↥| Name | MYELOPROF |
|---|---|
| Long name | Myeloproliferative diseases |
| Include | CML, POLYCYTVERA, CHRONMYELOPRO, THROMBOCYTAEMIA, MYELOFIBROSIS |
| First defined in version | DF2, additional |
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 890 | 477 | 413 |
| Unadjusted prevalence (%) | 0.41 | 0.39 | 0.44 |
| Mean age at first event (years) | 60.12 | 59.38 | 60.97 |
| Case fatality at 5-years (%) | 5.96 | 4.61 | 7.51 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 9.0 | 7.0 | 10.0 |
| Recurrence at 6 months (%) | 77.08 | 75.05 | 79.42 |
Survival analyses between endpoints
↥Plot
before Myeloproliferative diseases
after Myeloproliferative diseases
Loading survival analyses plot…
Table
Loading survival analyses table…